| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
3,886 |
1,836 |
$117K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,282 |
1,181 |
$64K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,359 |
1,269 |
$59K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
935 |
768 |
$56K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
393 |
350 |
$32K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
3,884 |
1,834 |
$29K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
480 |
474 |
$14K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
214 |
201 |
$3K |
| 87428 |
|
49 |
49 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
107 |
92 |
$995.35 |
| 90686 |
|
44 |
42 |
$825.68 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
41 |
40 |
$470.05 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
48 |
24 |
$442.98 |
| 99000 |
|
157 |
112 |
$403.86 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
13 |
13 |
$0.00 |